News Concordia and Actavis face UK pricing probe Firms colluded to hike prices, says competition watchdog.
News Pfizer under investigation over links with charities US authorities probing several other drugmakers amid pricing row.
News Biotech leaders unite against Trump travel ban Spokesman also causes confusion over pricing policy.
News Sanofi cholesterol drug can stay on US market - for now Sales of Praluent can continue during patent case appeal.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
